For financial incentives to be considered as the best form of solution to the crisis in organ and tissue donation, they have to work effectively and work better than alternative solutions. Examples of financial incentives working include Germany’s use of reductions in social insurance contributions if citizens attend smoking cessation sessions, screenings and dieting classes and a recent U.S. study which found that over a 3-month period participants offered $14 per percentage point of weight loss lost 4.7 pounds and participants offered $7 per percentage point of weight loss lost 3.0 lb compared with 2.0 lb among control group participants 4 (those who received no financial incentive). These are but two examples from worldwide use of financial incentives in motivating and changing behavior. However, there are some issues with the effectiveness of financial incentives for organ and tissue donation, mainly those of the wide and popular range of alternatives and the lack of tangibility for financially incentivized post-mortem donation. The introduction of financial incentives could lead to a reduction in altruistic donations, opponents of financial incentives argue. This decline in altruistic donations will lead to an overall decline in donations and therefore make the crisis even worse. However, financial incentives can easily work alongside altruism, since those who donate altruistically do so for family or friends - people donate for different reasons, and there is no evidence that financial incentives would cause people to stop donating. Even if there is a reduction in altruistic donations these can be more than made up for by the increase in donations caused by financial incentives. The main alternative to financial incentives is the presumed consent or “opt-out” system. Presumed consent asks the people to register to prevent their organs being used after death, as opposed to registering to allow use. This utilizes the perceived apathy of the population and increases the number of post-mortem donations dramatically without causing the same ethical and moral concerns as financial incentives. However, presumed consent has some serious problems, both practical and moral. It does not increase live donations whatsoever, and both people themselves and families of the deceased can simply refuse donation. It also raises questions regarding whether the state can claim people’s bodies without permission.
Table of Contents
1. Are Financial Incentives the Best Solution to the Crisis in Organ and Tissue Donation?
Objectives and Topics
This paper examines the viability and ethical implications of implementing financial incentives as a solution to the global organ and tissue donation crisis, arguing that such measures could effectively increase donation rates and reduce black market exploitation.
- Economic viability of financial incentives in organ transplantation
- Ethical debate regarding free will, altruism, and financial pressure
- Comparative analysis of financial incentives versus presumed consent systems
- Strategies for regulating organ donation to prevent exploitation and organ tourism
Excerpt from the Book
Are Financial Incentives the Best Solution to the Crisis in Organ and Tissue Donation?
One of the most important issues of the modern medical world is the global crisis in organ and tissue donation. This crisis is severe and is only becoming worse – mainly, that there are not enough donors, both living and post-mortem. A third of those already on the waiting list will die waiting for a donor1. This huge shortage has led, also, to a growth in an unregulated and highly illegal black market in organs, often involving organ tourism. This black market not only puts donors lives at risk but it exploits the poor and vulnerable, allowing the rich to purchase organs from often coerced, by actual force or situation, donors in abject poverty. Financial incentives potentially provide a solution to this immediate, life-threatening crisis.
The first and most practical aspect of this issue is whether or not financial incentives are economically viable. The introduction of such incentives would cause the redistribution of a significant monetary sum, and many would argue that it is not financially feasible in the current economic climate. At a time where public spending cuts are taking place worldwide, financial incentives may seem fiscally irresponsible and actually a damaging change in the allocation of funding, especially in regard to research and development of alternatives to living and post-mortem organ donation, such as stem cell research or xenotransplantation.
Summary of Chapters
Are Financial Incentives the Best Solution to the Crisis in Organ and Tissue Donation?: This chapter analyzes the economic feasibility of financial incentives, comparing them to alternative research areas like stem cell development and demonstrating their long-term cost-effectiveness in patient care.
Keywords
Organ donation, tissue donation, financial incentives, organ tourism, black market, altruism, presumed consent, free will, transplantation, medical ethics, healthcare policy, organ shortage, patient care, cost-effectiveness, living donors.
Frequently Asked Questions
What is the primary focus of this paper?
The paper focuses on the global crisis of organ and tissue donation and evaluates whether financial incentives are a viable and ethical solution to increase donor numbers.
What are the main themes explored?
Key themes include the economic feasibility of incentives, ethical concerns regarding donor exploitation, the role of altruism, and a comparison with the "opt-out" or presumed consent system.
What is the central research question?
The central question is whether financial incentives can serve as an effective, ethical, and economically sustainable solution to mitigate the severe shortage of organ donors.
Which methodology is applied?
The paper utilizes a comparative and analytical approach, weighing the economic benefits of saved healthcare costs against ethical concerns, while drawing upon international case studies and medical research data.
What does the main body address?
The main body addresses the economic costs versus savings of incentives, the ethical debate over human rights and free will, the potential impact on altruism, and the necessity of state regulation.
What are the characterizing keywords of the work?
The work is characterized by terms such as organ shortage, medical ethics, financial incentives, organ tourism, and healthcare regulation.
How do financial incentives compare to the "presumed consent" model?
The paper notes that while presumed consent increases post-mortem availability, it fails to address the need for live donations and carries its own set of moral and practical dilemmas regarding body ownership.
Can financial incentives coexist with altruistic donation?
The author argues that there is no evidence that incentives would stop altruistic donation; instead, they could act as a supplementary measure to increase the total number of available organs.
How does the author respond to the argument that incentives exploit the poor?
The author suggests that a regulated monopsony system, where the state is the sole buyer, would eliminate the predatory black market and prevent the rich from exploiting vulnerable donors.
Does the paper consider the health of the donors themselves?
Yes, the paper cites medical research indicating that kidney donors generally enjoy a quality of life equal to or better than that of the general population, challenging the idea that donation inherently causes harm.
- Arbeit zitieren
- David Wheeler (Autor:in), 2011, Are financial incentives the best solution to the crisis in organ and tissue donation?, München, GRIN Verlag, https://www.grin.com/document/175048
